We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBTX
3551
DELISTED
Veritex Holdings
VBTX
$824K ﹤0.01%
38,534
+32,593
+549% +$797K
ESPR
3552
CALL
DELISTED
Esperion Therapeutics
ESPR
$823K ﹤0.01%
17,900
+2,600
+17% +$125K
AUD
3553
DELISTED
Audacy, Inc.
AUD
$823K ﹤0.01%
144,168
+128,733
+834% +$857K
AVNS
3554
DELISTED
Avanos Medical
AVNS
$822K ﹤0.01%
18,357
+5,733
+45% +$300K
EXEL icon
3555
CALL
Exelixis
EXEL
$13.3B
$822K ﹤0.01%
41,800
-16,300
-28% -$291K
SCHL icon
3556
Scholastic
SCHL
$767M
$821K ﹤0.01%
20,389
+8,993
+79% +$391K
MFGP
3557
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$821K ﹤0.01%
39,372
+10,098
+34% +$216K
ACH
3558
Accendra Health
ACH
$237M
$820K ﹤0.01%
129,560
+41,243
+47% +$428K
PBI icon
3559
PUT
Pitney Bowes
PBI
$2.4B
$820K ﹤0.01%
138,800
-1,100
-0.8% -$7.92K
CNR
3560
Core Natural Resources Inc
CNR
$4.02B
$820K ﹤0.01%
25,875
+17,873
+223% +$657K
IPAR icon
3561
Interparfums
IPAR
$3.99B
$819K ﹤0.01%
12,485
+1,692
+16% +$102K
IVZ icon
3562
CALL
Invesco
IVZ
$13.1B
$815K ﹤0.01%
48,700
+200
+0.4% +$4K
MTSI icon
3563
MACOM Technology Solutions
MTSI
$19.2B
$815K ﹤0.01%
56,182
+3,315
+6% +$53.5K
TXRH icon
3564
Texas Roadhouse
TXRH
$13.5B
$815K ﹤0.01%
13,646
-12,504
-48% -$803K
RPM icon
3565
RPM International
RPM
$13.7B
$814K ﹤0.01%
13,848
-6,683
-33% -$409K
ARNA
3566
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$814K ﹤0.01%
20,900
+2,200
+12% +$86.4K
PAM icon
3567
Pampa Energía
PAM
$4.75B
$813K ﹤0.01%
25,542
+10,709
+72% +$347K
FAF icon
3568
First American
FAF
$7.66B
$811K ﹤0.01%
18,176
-37,706
-67% -$1.75M
KWEB icon
3569
CALL
KraneShares CSI China Internet ETF
KWEB
$5.64B
$810K ﹤0.01%
21,600
-3,100
-13% -$131K
TRHC
3570
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$810K ﹤0.01%
12,703
+813
+7% +$57.6K
IIN
3571
DELISTED
IntriCon Corporation
IIN
$810K ﹤0.01%
30,724
+28,418
+1,232% +$1.08M
ZUMZ icon
3572
Zumiez
ZUMZ
$332M
$809K ﹤0.01%
42,210
-10,114
-19% -$214K
AMKR icon
3573
Amkor Technology
AMKR
$12.4B
$808K ﹤0.01%
123,141
+112,995
+1,114% +$745K
NUGT icon
3574
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$848M
$808K ﹤0.01%
9,226
+7,351
+392% +$540K
OLLI icon
3575
Ollie's Bargain Outlet
OLLI
$4.44B
$808K ﹤0.01%
12,158
+8,452
+228% +$703K

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.